Stay updated on Pfizer Press Releases

Sign up to get notified when there's something new on the Pfizer Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Pfizer Press Releases page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a new press release entry for Pfizer’s BRAFTOVI regimen on 02.17.2026 and introduced the Medicines and Research and Pipeline categories. Removed the Research and Corporate categories and the press release 'Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma' dated 12.09.2025.
    Difference
    1%
    Check dated 2026-02-18T16:47:35.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added two new press releases: 'Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans' (02.05.2026) and 'FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need' (02.06.2026). Removed two older press releases: 'European Medicines Agency Validates Type II Variation Application for PADCEV™ with KEYTRUDA™ for Certain Patients with Muscle-Invasive Bladder Cancer' (12.01.2025) and 'HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors' (12.06.2025).
    Difference
    3%
    Check dated 2026-02-11T14:11:16.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    New archive entries for February 2026 and December 16, 2025 were added, including 'Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance' and 'Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial'. The archive also removes the December 16 webcast invitation and the 11.21.2025 entry announcing that PADCEV plus Keytruda received FDA approval for certain bladder cancer patients.
    Difference
    8%
    Check dated 2026-02-04T10:25:40.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Added a new press release entry: 'Pfizer’s BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer' (01.10.2026) under Medicines. Removed the item 'Pfizer Completes Acquisition of Metsera' (11.13.2025) from Corporate.
    Difference
    2%
    Check dated 2026-01-14T03:27:11.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    January 2026 entries (01.05.2026) were added to the Press Release Archive, and the 11.12.2025 entry was removed. The archive now reflects the latest releases for the start of 2026.
    Difference
    2%
    Check dated 2026-01-07T01:44:27.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added three December 2025 press releases to the Pfizer Press Release Archive and removed three November 2025 entries.
    Difference
    8%
    Check dated 2025-12-23T21:16:30.000Z thumbnail image

Stay in the know with updates to Pfizer Press Releases

Enter your email address, and we'll notify you when there's something new on the Pfizer Press Releases page.